The Top 100 Drugs

The pharmaceutical industry is massive, both in range of products and in financial values. These are the top 200 drugs (ranked in descending order according to total sales in 20010, $), and the co...

Sunovion Targets Respiratory Drug in $430M Deal for Elevation Pharma

Sticking with a lean business model has paid off big for San Diego’s Elevation Pharmaceuticals, which has agreed to a buyout offer from Marlborough, MA-based Sunovion Pharmaceuticals that could even...

Sunovion Layoffs?

Unfortunately, I'm hearing talk of a big layoff at Sunovion (neé Sepracor). Anyone have any details? Their business has been in developing trouble for some time now. . .

Sunovion Presents New Analyses that Continue to Support ZETONNA (ciclesonide) Nasal Aerosol's Efficacy in SAR and PAR

Post-Hoc Analyses Based on the Pooled Studies Support Efficacy in SAR and PAR Patients MARLBOROUGH, Mass.--(BUSINESS WIRE)--Feb 25, 2013 - Sunovion Pharmaceuticals Inc. (Sunovion) today announced resu...

Mylan settles patent litigation relating to Sunovion's Brovana product

Mylan Inc., a global pharmaceutical company committed to setting new standards in healthcare, announced that Mylan Specialty L.P., f/k/a Dey Pharma, LP, has entered into an agreement with Sunovion Pha...

Sunovion Announces FDA Acceptance for Review of New Drug Application Resubmission for Stedesa (eslicarbazepine acetate) as a Once-Daily Adjunctive Therapy for Partial-onset Seizures in Adults with Epilepsy

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Feb 27, 2013 - Sunovion Pharmaceuticals Inc. (Sunovion) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Company's New...

Mylan Announces Settlement Agreement in Patent Infringement Litigation Relating to Sunovion's Brovana® Product

PITTSBURGH, May 24, 2012 /- Mylan Inc. (Nasdaq: MYL ) today announced that Mylan Specialty L.P., f/k/a Dey Pharma, L.P., has entered into an agreement with Sunovion Pharmaceuticals Inc., f/k/a...

Dainippon Sumitomo Pharma Co., Ltd.'s U.S. Subsidiary Sunovion Pharmaceuticals Inc. to Acquire Elevation Pharmaceuticals, Inc.

August 31, 2012 Osaka, Japan, August 31 2012 – Dainippon Sumitomo Pharma Co., Ltd (DSP) (Headquarters: Osaka, Japan; President: Masayo Tada) announces today that its wholly-owned subsidiary Suno...

US FDA starts clock on Sunovion review for Latuda in biopolar

The US FDA accepted Sunovion Pharmaceuticals' supplemental new drug applications (sNDAs) for Latuda (lurasidone HCl) as a monotherapy and as an adjunctive therapy to lithium or valproate to treat adu...

Development of an Ease-of-Use Remote Healthcare System Architecture Using RFID and Networking Technologies.

The study aims to provide an ease-of-use approach for senior patients to utilize remote healthcare systems. An ease-of-use remote healthcare system (RHS) architecture using RFID (Radio Frequency Ident...

Synthesis and Pharmacological Characterization of Bicyclic Triple Reuptake Inhibitor 3-Aryl Octahydrocyclopentacpyrrole Analogues.

The present work expands the chemical space known to offer potent inhibition of the serotonin transporter (SERT), norepinephrine transporter (NET), and dopamine transporter (DAT) and discloses novel b...

Structural, Kinetic, and Pharmacodynamic Mechanisms of d-Amino Acid Oxidase Inhibition by Small Molecules.

We characterized the mechanism and pharmacodynamics of five structurally distinct inhibitors of d-amino acid oxidase. All inhibitors bound the oxidized form of human enzyme with affinity slightly high...

Measuring motor speed through typing: a surrogate for the finger tapping test.

Motor speed is an important indicator and predictor of both cognitive and physical function. One common assessment of motor speed is the finger-tapping test (FTT), which is typically administered as p...

Accessibility of special clinical laboratory tests in Hungary.

The Hungarian Society of Laboratory Medicine launches a Laboratory Assay Finder after more than a year of preparatory work. The purpose is that all laboratory and clinical specialists can have access...